Income StatementBalance SheetCash FlowSegments
Bristol-Myers Squibb logo

Bristol-Myers Squibb Cash Flow Statement

Operating, investing, and financing cash movements

Bristol-Myers Squibb generated $13.3B in operating cash flow over the trailing twelve months. After $1.4B in capital expenditures, free cash flow was $11.9B. Free cash flow decreased 0.1% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$13.3BNet Cash From Investing (TTM)-$3.8BNet Cash From Financing (TTM)-$10.9BCapital Expenditures (TTM)$1.4BDepreciation And Amortization Cf (TTM)$3.6BNet Change In Cash (TTM)-$1.3B
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$121.42B
P/E Ratio16.69
ROE38.84%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Other non-cash income (expense)—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Change in accounts payable$517.0M-$85.0M—$160.0M-$90.0M$409.0M
Change in income taxes payable/receivable$0.0$54.0M-$621.0M$887.0M-$324.0M$187.0M
Change in inventories—$169.0M—$90.0M—-$14.0M
Other working capital changes-$725.0M$1.1B——-$1.1B$1.6B
Change in receivables-$143.0M-$15.0M$484.0M——-$1.7B
Deferred income taxes-$791.0M$223.0M-$437.0M-$359.0M-$392.0M$161.0M
Depreciation and amortization$1.9B$1.0B$1.0B$1.0B$977.0M$594.0M
Other Non-Cash Income (Expense)—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Other Non-cash Income (Expense)—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Other Non-cash Income (Expense)—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Realized Gain (Loss) on Disposal of Equity Method Investment—-$78.0M-$22.0M$190.0M$190.0M$134.0M
Net cash from operating activities$4.4B$2.0B$3.9B$6.3B$2.0B$1.1B
Net income$0.0$2.5B$1.3B$2.2B$1.1B$2.7B
Other non-cash income (expense)—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Acquired IPRD$30.0M$188.0M$1.5B$633.0M$1.4B$94.0M
Contingent consideration fair value adjustments$0.0$0.0$336.0M$0.0$15.0M—
Divestiture Gains And Royalties$279.8M$292.0M———$34.0M
Impairment of assets held for sale$2.0B$5.0M$313.0M$196.0M$584.0M$412.0M
Accrued liabilities—-$627.0M$881.0M$1.7B-$2.4B-$3.5B
Other Noncash Income (Expense)—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Other Non-cash Income and Expense—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Other Non-Cash Adjustments—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Other Non-Cash Income and Expense—-$5.0M$7.0M$74.0M-$308.0M-$21.0M
Stock-based compensation$120.0M$144.0M$137.0M$139.0M$133.0M$146.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from other short-term debt—$368.0M$58.0M$5.0M—$321.0M
Proceeds from other short-term debt—$368.0M$58.0M$5.0M—$321.0M
Repayments of debt$0.0$0.0$643.0M$229.0M$10.1B$500.0M
Dividends paid$1.2B$1.3B$1.3B$1.3B$1.3B$1.3B
Stock option proceeds and other, net-$19.0M-$103.0M$0.0-$3.0M-$33.0M-$98.0M
Proceeds from Issuance of Commercial Paper—$0.0$0.0$0.0$0.0—
Proceeds from other short-term debt—$368.0M$58.0M$5.0M—$321.0M
Repayment of commercial paper———$0.0$0.0—
Net cash from financing activities—-$993.0M-$1.8B-$1.5B-$6.0B-$1.6B
Proceeds from Bridge Loan—$368.0M$58.0M$5.0M—$321.0M
Proceeds from Other Short-Term Debt—$368.0M$58.0M$5.0M—$321.0M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$47.0M$78.0M$285.0M$1.9B$1.7B$65.0M
Capital expenditures$378.0M$260.0M$361.0M$320.0M$370.0M$347.0M
Proceeds from Sale of Retained Ownership Interests$205.0M$12.0M$0.0$49.0M$16.0M$391.0M
Divestiture and other proceeds$274.8M$243.0M———$312.0M
Proceeds From Sale And Maturity Of Available For Sale Securities$62.0M$220.0M$524.0M$829.0M$402.0M$359.0M
Proceeds from disposal of certain strategic investments$205.0M$12.0M$0.0$49.0M$16.0M$391.0M
Proceeds from Sale of Seagen Inc. Common Stock$205.0M$12.0M$0.0$49.0M$16.0M$391.0M
Net cash from investing activities-$196.0M-$499.0M-$473.0M-$1.7B-$1.5B-$131.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$4.1B$1.7B$3.6B$6.0B$1.6B$757.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$147.0M$66.0M$128.0M$0.0$5.0M-$48.0M
Net increase (decrease) in cash—$528.0M$1.7B$3.1B-$5.5B-$635.0M